Scion Team Page Image

Team

United by our conviction in the power of therapeutic innovation to improve human health.

Meet the Scion team

The ten companies our team has been part of founding or building over the past ten years have realized uncommon success and, together, have given rise to >15 clinical-stage therapeutics, advanced six promising therapeutics into pivotal clinical trials and have generated >$14 billion in combined public equity value and announced M&A proceeds. We are excited to discover what the future holds.

Romesh Subramanian

Romesh Subramanian, PhD

Venture Partner

Romesh is a Venture Partner at Scion Life Sciences. He brings over 20 years of experience in pharma and biotech as a scientist, founder and entrepreneur. He founded and led companies developing nucleic acid therapeutics, biologics and antibody conjugates. Prior to joining Scion Life Sciences, Romesh was President and CEO of Ascidian Therapeutics developing RNA exon editing medicines. Previously, he was an EIR at Atlas Ventures and the founding CEO of Dyne Therapeutics (NASDAQ: DYN) which develops antibody conjugates for neuromuscular diseases. While at Atlas Venture he also co-founded and led R&D at RaNA Therapeutics, later known as Translate Bio (NASDAQ: TBIO) and acquired by Sanofi (NASDAQ: SNY). Prior to Atlas Ventures, Romesh led mRNA and antibody therapeutics at Alexion and developed nucleic acid therapies for metabolic disease and oncology at Pfizer.

Romesh obtained his B.S. from Loyola College, an M.S. from Duke University, and a Ph.D. from Emory University.

LinkedIn